Jung-Min Lee

Jung-Min Lee is a South Korean-American medical oncologist and physician-scientist focused on the early clinical drug development and translational studies of targeted agents in BRCA mutation-associated breast or ovarian cancer, high-grade epithelial ovarian cancer, and triple-negative breast cancer. She is a senior investigator in the Women's Malignancies Branch at the National Cancer Institute.

Early life and education Lee is a earned a MD at Yonsei University Wonju College of Medicine. She completed a residency in internal medicine at Holy Family Hospital, Catholic University of Korea. At the age of 26, she immigrated to the United States. Lee conducted a research fellowship in pathology and cell biology at Thomas Jefferson University and residency training in internal medicine at the Albert Einstein College of Medicine. She completed a clinical research fellowship on breast cancer functional imaging at the Memorial Sloan Kettering Cancer Center. From 2008 to 2012, Lee was a medical oncology and hematology fellow at the National Cancer Institute's (NCI) Medical Oncology Branch (MOB).

Additionally, Lee has published clinical guidelines for the management of acromegaly, adrenal incidenteloma, and atrial fibrillation.

Awards and honors Lee was awarded the 2011 Jane C. Wright M.D. Young Investigator Award from the American Society of Clinical Oncology and the 2012 New York Ovarian Cancer Research Award from the Foundation for Women's Cancers.